Evidence map›Paper›PMID 25930097›Full record

Trial reportGastrointestinal endoscopy2015

Linear-array EUS improves detection of pancreatic lesions in high-risk individuals: a randomized tandem study.

Eun Ji Shin, Mark Topazian, Michael G Goggins, Sapna Syngal, John R Saltzman, Jeffrey H Lee, James J Farrell, Marcia I Canto

Abstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Gastrointestinal endoscopy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
2.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Observational
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Pancreatic Cancer Screening.Current treatment options in gastroenterology · 2017
    Review
  13. Article
  14. Endoscopic ultrasonography.Gastrointestinal endoscopy · 2012
    Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Eun Ji ShinDivision of Gastroenterology and Hepatology, Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.
Mark TopazianDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
Michael G GogginsDivision of Gastroenterology and Hepatology, Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.
Sapna SyngalDivision of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Division of Gastroenterology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
John R SaltzmanDivision of Gastroenterology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Jeffrey H LeeDepartment of Gastroenterology, Hepatology, and Nutrition, MD Anderson Cancer Center, Houston, Texas, USA.
James J FarrellSection of Digestive Diseases, Yale University School of Medicine, New Haven, Connecticut, USA.
Marcia I CantoDivision of Gastroenterology and Hepatology, Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.
Johns Hopkins University · USBrigham and Women's Hospital · USMayo Clinic · USThe University of Texas MD Anderson Cancer Center · USYale University · US

Funding

Tumor Antigens for Individual Signatures and TherapyP50CA062924 · NCI · JOHNS HOPKINS UNIVERSITY · PI LENNON, ANNE MARIE · 1993 to 2022
$54.6M
Using Markers to Improve Pancreatic Cancer ScreeningR01CA176828 · NCI · JOHNS HOPKINS UNIVERSITY · PI GOGGINS, MICHAEL G. · 2013 to 2024
$4.1M
NCI NIH HHS 2 P50 CA62924NCI NIH HHS P50 CA062924NCI NIH HHS R01 CA176828
6 · The paper itself

Abstract

backgroundStudies comparing linear and radial EUS for the detection of pancreatic lesions in an asymptomatic population with increased risk for pancreatic cancer are lacking.

objectivesTo compare pancreatic lesion detection rates between radial and linear EUS and to determine the incremental diagnostic yield of a second EUS examination.

designRandomized controlled tandem study.

settingFive academic centers in the United States. PATIENTS: Asymptomatic high-risk individuals (HRIs) for pancreatic cancer undergoing screening EUS.

interventionsLinear and radial EUS performed in randomized order. MAIN OUTCOME MEASUREMENTS: Pancreatic lesion detection rate by type of EUS, miss rate of 1 EUS examination, and incremental diagnostic yield of a second EUS examination (second-pass effect).

resultsTwo hundred seventy-eight HRIs were enrolled, mean age 56 years (43.2%), and 90% were familial pancreatic cancer relatives. Two hundred twenty-four HRIs underwent tandem radial and linear EUS. When we used per-patient analysis, the overall prevalence of any pancreatic lesion was 45%. Overall, 16 of 224 HRIs (7.1%) had lesions missed during the initial EUS that were detected by the second EUS examination. The per-patient lesion miss rate was significantly greater for radial followed by linear EUS (9.8%) than for linear followed by radial EUS (4.5%) (P = .03). When we used per-lesion analysis, 73 of 109 lesions (67%) were detected by radial EUS and 99 of 120 lesions (82%) were detected by linear EUS (P < .001) during the first examination. The overall miss rate for a pancreatic lesion after 1 EUS examination was 47 of 229 (25%). The miss rate was significantly lower for linear EUS compared with radial EUS (17.5% vs 33.0%, P = .007). LIMITATIONS: Most detected pancreatic lesions were not confirmed by pathology.

conclusionLinear EUS detects more pancreatic lesions than radial EUS. There was a "second-pass effect" with additional lesions detected with a second EUS examination. This effect was significantly greater when linear EUS was used after an initial radial EUS examination.

Indexed as

AdultAgedAged, 80 and overEarly Detection of CancerEndosonographyFemaleFollow-Up StudiesHumansMagnetic Resonance ImagingMaleMiddle AgedPancreasPancreatic NeoplasmsProspective StudiesReproducibility of ResultsRisk Factors

Identifiers

PMID25930097
PMCPMC4609234
OpenAlexW2079164620

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.